Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Not all patients respond to current therapy<br />
Gold standard therapy<br />
anti-TNF + MTX<br />
% ACR70 Responders<br />
Unmet Medical Need<br />
Only 1 of 3 patients receives<br />
significant benefit<br />
anti-TNF + MTX<br />
anti-TNF alone<br />
MTX alone<br />
ACR 70=70% Improvement in:<br />
Global disease activity - patient<br />
Global disease activity - physician<br />
Patient assessment of Pain<br />
Physical disability<br />
Acute phase reactants – CRP,ESR<br />
58